Open label safety and efficacy pilot to study mitigation of equine recurrent uveitis through topical suppressor of cytokine signaling-1 mimetic peptide

Equine recurrent uveitis (ERU) is a painful and debilitating autoimmune disease and represents the only spontaneous model of human recurrent uveitis (RU). Despite the efficacy of existing treatments, RU remains a leading cause of visual handicap in horses and humans. Cytokines, which utilize Janus k...

Descripción completa

Detalles Bibliográficos
Autores principales: Plummer, Caryn E., Polk, Timothy, Sharma, Jatin, Bae, Sanghyo Sarah, Barr, Olivia, Jones, Amari, Kitchen, Holly, Wilhelmy, Michelle, Devin, K., Clay Smith, W., Kolaczkowski, Bryan D., Larkin, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065145/
https://www.ncbi.nlm.nih.gov/pubmed/35505065
http://dx.doi.org/10.1038/s41598-022-11338-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065145/
https://www.ncbi.nlm.nih.gov/pubmed/35505065
http://dx.doi.org/10.1038/s41598-022-11338-x

Ejemplares similares